Mourad F. Rezk

To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars

Mourad F. Rezk, Burkhard Pieper · Advances in Therapy · 2018 · 42 citations · Full text

Pharmacy, Pharmacology, Bioequivalence +13

Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe

Kunal Thakur, Anna Biberger, Alexandra Handrich et al. · Rheumatology and Therapy · 2016 · 33 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +8

Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe

Kunal Thakur, Anna Biberger, Alexandra Handrich et al. · Rheumatology and Therapy · 2016 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial

Xiaomei Leng, Piotr Leszczyński, Sławomir Jeka et al. · The Lancet Rheumatology · 2023 · 20 citations

Medicine, Immunology, Pharmacotherapy +14

Batch-to-Batch Consistency of SB4 and SB2, Etanercept and Infliximab Biosimilars

Hans C. Ebbers, Bjørn Fehrmann, M. Ottosen et al. · BioDrugs · 2020 · 13 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +13